Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/JNJ-26489112> ?p ?o }
Showing triples 1 to 55 of
55
with 100 triples per page.
- JNJ-26489112 abstract "JNJ-26489112 is an anticonvulsant drug that was being developed by Johnson & Johnson for the treatment of epilepsy. JNJ-26489112 was designed as a successor to topiramate. It was expected to have fewer side effects than topiramate because it lacks activity against carbonic anhydrase.JNJ-26489112 was also being studied as a treatment for major depressive disorder.".
- JNJ-26489112 thumbnail JNJ-26489112_structural_formula.png?width=300.
- JNJ-26489112 wikiPageExternalLink S0273230014000518.
- JNJ-26489112 wikiPageID "42193326".
- JNJ-26489112 wikiPageLength "5017".
- JNJ-26489112 wikiPageOutDegree "10".
- JNJ-26489112 wikiPageRevisionID "707011255".
- JNJ-26489112 wikiPageWikiLink Anticonvulsant.
- JNJ-26489112 wikiPageWikiLink Carbonic_anhydrase.
- JNJ-26489112 wikiPageWikiLink Category:Anticonvulsants.
- JNJ-26489112 wikiPageWikiLink Category:Benzodioxins.
- JNJ-26489112 wikiPageWikiLink Category:Johnson_&_Johnson.
- JNJ-26489112 wikiPageWikiLink Epilepsy.
- JNJ-26489112 wikiPageWikiLink JNJ-26990990.
- JNJ-26489112 wikiPageWikiLink Johnson_&_Johnson.
- JNJ-26489112 wikiPageWikiLink Major_depressive_disorder.
- JNJ-26489112 wikiPageWikiLink Topiramate.
- JNJ-26489112 wikiPageWikiLinkText "JNJ-26489112".
- JNJ-26489112 c "9".
- JNJ-26489112 chemspiderid "9790860".
- JNJ-26489112 cl "1".
- JNJ-26489112 h "11".
- JNJ-26489112 inchi "1".
- JNJ-26489112 inchikey "KXSAIQPPGSSNKX-ZETCQYMHBY".
- JNJ-26489112 iupacName "-N-[methyl]sulfamide".
- JNJ-26489112 molecularWeight "278.713".
- JNJ-26489112 n "2".
- JNJ-26489112 o "4".
- JNJ-26489112 pubchem "11616111".
- JNJ-26489112 s "1".
- JNJ-26489112 smiles "NSNC[C@H]1COC2=CC=CC=C2".
- JNJ-26489112 stdinchi "1".
- JNJ-26489112 stdinchikey "KXSAIQPPGSSNKX-ZETCQYMHSA-N".
- JNJ-26489112 wikiPageUsesTemplate Template:Anticonvulsants.
- JNJ-26489112 wikiPageUsesTemplate Template:Cite_journal.
- JNJ-26489112 wikiPageUsesTemplate Template:Infobox_drug.
- JNJ-26489112 wikiPageUsesTemplate Template:Ion_channel_modulators.
- JNJ-26489112 wikiPageUsesTemplate Template:Reflist.
- JNJ-26489112 subject Category:Anticonvulsants.
- JNJ-26489112 subject Category:Benzodioxins.
- JNJ-26489112 subject Category:Johnson_&_Johnson.
- JNJ-26489112 hypernym Drug.
- JNJ-26489112 type ChemicalSubstance.
- JNJ-26489112 type Drug.
- JNJ-26489112 type ChemicalObject.
- JNJ-26489112 type Thing.
- JNJ-26489112 type Q8386.
- JNJ-26489112 comment "JNJ-26489112 is an anticonvulsant drug that was being developed by Johnson & Johnson for the treatment of epilepsy. JNJ-26489112 was designed as a successor to topiramate. It was expected to have fewer side effects than topiramate because it lacks activity against carbonic anhydrase.JNJ-26489112 was also being studied as a treatment for major depressive disorder.".
- JNJ-26489112 label "JNJ-26489112".
- JNJ-26489112 sameAs Q16997761.
- JNJ-26489112 sameAs m.0_yfwy7.
- JNJ-26489112 sameAs Q16997761.
- JNJ-26489112 wasDerivedFrom JNJ-26489112?oldid=707011255.
- JNJ-26489112 depiction JNJ-26489112_structural_formula.png.
- JNJ-26489112 isPrimaryTopicOf JNJ-26489112.